Levetiracetam and lamotrigine are the two most commonly prescribed seizure medications worldwide. Levetiracetam (brand name Keppra) is often the first drug reached for in emergency and hospital settings because it can be started quickly without a slow dose increase. Lamotrigine (brand name Lamictal) is widely favored for long-term management because it works across multiple seizure types and tends to be well tolerated. Which one a doctor chooses depends on the type of epilepsy, how quickly seizures need to be controlled, and how a patient responds to side effects.
How Levetiracetam and Lamotrigine Compare
Levetiracetam’s biggest advantage is speed. You can reach a full therapeutic dose within days, which makes it the go-to choice when seizures need to be stopped quickly, such as after a first seizure in the emergency room or following brain surgery. It works for both focal seizures (starting in one area of the brain) and generalized seizures (affecting the whole brain), and it has very few interactions with other medications.
Lamotrigine requires a slow, weeks-long dose increase to reduce the risk of a serious skin rash. That makes it less practical in urgent situations. But for ongoing epilepsy management, it has a strong track record. In clinical trials for generalized tonic-clonic seizures, lamotrigine reduced seizure frequency by about 67% compared to 34% with placebo, and 72% of patients on the drug experienced at least a 50% drop in seizure frequency. It’s approved for use in adults and children aged two and older, both as an add-on therapy and as a standalone treatment. Doctors also value it in cases where it’s unclear whether seizures are focal or generalized, since it covers both.
Side Effects That Matter Most
The side effect profiles of these two drugs differ in ways that significantly affect daily life. Levetiracetam is well known for causing mood and behavioral changes. In patient-reported data, anger was the most frequently mentioned side effect at about 19%, followed by depression (18%), fatigue (14%), mood swings (13%), and irritability (11%). For some people these effects are mild, but for others they’re severe enough to require switching medications. The term “Keppra rage” is informal but widely recognized among patients and neurologists alike.
Lamotrigine’s side effect profile skews milder for most people. The most commonly reported issues include anxiety (7%), depression (7%), skin rash (6%), insomnia (5%), headaches (5%), and dizziness (4%). The rash deserves special attention: while most lamotrigine-related rashes are harmless, in rare cases the drug can trigger a severe, potentially life-threatening skin reaction called Stevens-Johnson syndrome. This is why the dose must be increased very gradually over several weeks.
Older Medications Still in Use
Carbamazepine and phenytoin were the backbone of epilepsy treatment for decades and are still prescribed today, though less frequently as first-line options for new diagnoses. Carbamazepine remains a strong choice for focal seizures and is the top recommendation for trigeminal neuralgia, a condition causing severe facial pain. Common side effects include dizziness, drowsiness, nausea, and balance problems, and these tend to be dose-dependent, meaning they get worse at higher doses.
One practical drawback of carbamazepine is that it powerfully affects liver enzymes responsible for breaking down other drugs. This means it can reduce the effectiveness of many common medications, including birth control pills, other seizure drugs, and blood thinners. Patients on carbamazepine often need dose adjustments for their other prescriptions. Phenytoin shares similar drug interaction issues and requires blood level monitoring, which has made both drugs less convenient than newer alternatives.
Valproate: Effective but Restricted
Sodium valproate (brand name Depakote or Epilim) is one of the most effective medications for generalized epilepsy and remains on the WHO’s list of essential medicines. However, its use has been significantly restricted in women and girls of childbearing age due to severe reproductive risks.
About 1 in 9 babies (11%) born to women taking valproate during pregnancy will have a birth defect, including spina bifida and malformations of the face, skull, limbs, or heart. The developmental risks are even more striking: 3 to 4 out of every 10 children exposed to valproate in the womb may experience problems with early development, including delayed walking and talking, lower intellectual ability, poor language skills, memory issues, and higher rates of autism spectrum disorders. Because of these risks, current regulations require that valproate only be prescribed to patients under 55 when two specialists agree that other treatments have failed and the benefits outweigh the risks. Women who can become pregnant must follow a formal pregnancy prevention program.
How Seizure Type Guides the Choice
Epilepsy isn’t one condition. It’s a group of disorders, and the type of seizure you have largely determines which medication works best. Focal seizures, which start in one specific brain region, respond well to most of the common medications, including levetiracetam, lamotrigine, and carbamazepine. Generalized seizures, which involve the entire brain from the start, have fewer effective options. Lamotrigine, levetiracetam, and valproate all work here, but carbamazepine can actually make certain generalized seizure types worse, particularly absence seizures.
For people with a mixed seizure pattern or an uncertain diagnosis, lamotrigine is often preferred precisely because it’s effective across the widest range of seizure types without the risk of worsening any particular one.
Cost Differences Are Significant
All of the most common seizure medications are available as generics, which makes a major difference in affordability. The average cost per unit of generic seizure medications in the U.S. has actually decreased slightly in recent years, dropping to about $1.26 per unit. Brand-name versions, by contrast, have climbed to an average of $15.43 per unit. That price gap has ballooned to over 3,400%, meaning a brand-name version can cost more than 34 times its generic equivalent.
Formulation matters too. Generic immediate-release tablets are dramatically cheaper than extended-release or delayed-release versions of the same drug, with cost differences reaching nearly 7,800% in some cases. If cost is a concern, asking specifically about immediate-release generics can save substantial money. That said, some patients do better on extended-release formulations because they provide more stable drug levels throughout the day and require fewer daily doses, so the choice involves trade-offs.
What Starting Treatment Looks Like
If you’re prescribed levetiracetam, you’ll typically reach your target dose within a week or two. Side effects, if they appear, usually show up early. Lamotrigine is a slower process. You’ll start at a low dose and increase it every two weeks over the course of roughly six to eight weeks. The exact schedule depends on what other medications you’re taking: if you’re also on valproate, the starting dose is lower and the ramp-up is slower, because valproate slows lamotrigine’s breakdown in your body. If you’re on enzyme-inducing drugs like carbamazepine or phenytoin, you’ll start higher and aim for a higher maintenance dose, typically 200 to 400 mg per day instead of 100 to 200 mg.
Most people try one medication first, and if it doesn’t control seizures or causes intolerable side effects, they switch to another. About two-thirds of people with epilepsy achieve good seizure control with medication, though it sometimes takes trying two or three drugs before finding the right fit.